Binding of a novel SMG-1–Upf1–eRF1–eRF3 complex (SURF) to the exon junction complex triggers Upf1 phosphorylation and nonsense-mediated mRNA decay

  1. Isao Kashima1,6,
  2. Akio Yamashita1,6,
  3. Natsuko Izumi1,
  4. Naoyuki Kataoka2,
  5. Ryo Morishita3,
  6. Shinichi Hoshino4,
  7. Mutsuhito Ohno2,
  8. Gideon Dreyfuss5, and
  9. Shigeo Ohno1,7
  1. 1Department of Molecular Biology, Yokohama City University School of Medicine, Yokohama 236-0004, Japan; 2Institute for Virus Research, Kyoto University, Kyoto 606-8507, Japan; 3CellFree Sciences, Ono-cho,Tsurumi-ku,Yokohama 230-0046, Japan; 4Preventive Nutraceutical Sciences, Nagoya City University, Nagoya 467-8603, Japan; 5Howard Hughes Medical Institute and Department of Biochemistry and Biophysics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA

Abstract

Nonsense-mediated mRNA decay (NMD) is a surveillance mechanism that degrades mRNA containing premature termination codons (PTCs). In mammalian cells, recognition of PTCs requires translation and depends on the presence on the mRNA with the splicing-dependent exon junction complex (EJC). While it is known that a key event in the triggering of NMD is phosphorylation of the trans-acting factor, Upf1, by SMG-1, the relationship between Upf1 phosphorylation and PTC recognition remains undetermined. Here we show that SMG-1 binds to the mRNA-associated components of the EJC, Upf2, Upf3b, eIF4A3, Magoh, and Y14. Further, we describe a novel complex that contains the NMD factors SMG-1 and Upf1, and the translation termination release factors eRF1 and eRF3 (SURF). Importantly, an association between SURF and the EJC is required for SMG-1-mediated Upf1 phosphorylation and NMD. Thus, the SMG-1-mediated phosphorylation of Upf1 occurs on the association of SURF with EJC, which provides the link between the EJC and recognition of PTCs and triggers NMD.

Keywords

Footnotes

  • Supplemental material is available at http://www.genesdev.org.

  • Article and publication are at http://www.genesdev.org/cgi/doi/10.1101/gad.1389006.

  • 6 These authors contributed equally to this work.

  • 7 Corresponding author.

    7 E-MAIL ohnos{at}med.yokohama-cu.ac.jp; FAX 81-45-785-4140.

    • Accepted December 13, 2005.
    • Received October 31, 2005.

Related Article

| Table of Contents

Life Science Alliance